LBPO.BCS02 · 生物信息与计算 · Late-Breaking
利用样本特异性错误谱改进双链测序数据中的突变检测
Improved mutation detection in duplex sequencing data with sample-specific error profiles
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
双链测序能够高度准确地检测罕见的体细胞突变,但现有的变异检测工具往往依赖于特定协议的启发式方法,从而限制了灵敏度、可重复性和跨研究可比性。我们提出DupCaller,这是一种概率变异检测工具,可构建样本特异性错误谱并应用链感知(strand-aware)统计模型进行突变检测。在50个合成数据集中,DupCaller识别出的单碱基置换(SBS)比一种最先进方法多1.25倍,插入缺失(indel)多1.41倍,同时表现出相同或更优的精确度。在三个用马兜铃酸处理的双链测序细胞系中,它恢复了预期的突变特征,同时检测到的SBS多3.5倍,indel多2.8倍。在93个组织样本(包括神经元、脐带血、精子、唾液和血液)中,DupCaller显示出一致的增益,检测到的突变多1.21至2.7倍。灵敏度随样本重复率而扩展,在最佳条件下产生约1.5倍的突变,在其他工具失效的低重复样本中则产生超过3倍的突变。这些结果确立了DupCaller作为一种稳健且可扩展的解决方案,用于在多样的生物学和技术背景下进行双链测序中的体细胞突变分析。
查看英文原文 English abstract
Duplex sequencing enables highly accurate detection of rare somatic mutations, but existing variant callers often rely on protocol-specific heuristics that limit sensitivity, reproducibility, and cross-study comparability. We present DupCaller, a probabilistic variant caller that builds sample-specific error profiles and applies a strand-aware statistical model for mutation detection. Across 50 synthetic datasets, DupCaller identified 1.25-fold more single-base substitutions (SBSs) and 1.41-fold more indels than a state-of-the-art method, while exhibiting equal or better precision. In three duplex-sequenced cell lines treated with aristolochic acid, it recovered expected mutational signatures while detecting 3.5-fold more SBSs and 2.8-fold more indels. In 93 tissue samples-including neurons, cord blood, sperm, saliva, and blood-DupCaller showed consistent gains, detecting 1.21- to 2.7-fold more mutations. Sensitivity scaled with sample duplication rate, yielding approximately 1.5-fold more mutations under optimal conditions and over 3-fold more in low-duplication samples where other tools falter. These results establish DupCaller as a robust and scalable solution for somatic mutation profiling in duplex sequencing across diverse biological and technical contexts.
利益披露 Disclosure
Y. Cheng, None..
S. P. Nandi, None..
L. Culibrk, None..
A. Kristin, None..
I. Stuewe, None..
S. Al-Azzam, None..
M. Petljak, None..
L. B. Alexandrov, None.